// App-Quantinova.ai

Sa1197 : Effects of Vitamin D Supplementation on Intestinal Permeability, Plasma Cathelicidin and Human Beta-Defensin-2 in Crohn's Disease: Results From a Randomised Double-Blind Placebo-Controlled Study

Researchers

Presenter

  • Adrian Martineau

Principal Investigators

  • Claire Greiller

  • Chun Seng Lee

  • Deirdre McNamara

  • Subrata Ghosh

  • Jon Meddings

  • Maria -Sullivan

Medical Centers

  • Barts and The London School of Medicine, Queen Mary University of London, London, United Kingdom

  • School of Medicine, Trinity College Dublin, Dublin, Ireland

  • Internal Medicine, University of Calgary, Calgary, AB, Canada

Locations

  • Ireland

  • United Kingdom

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Musculoskeletal

Disease

  • Crohn's disease

  • Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis

Biomarkers

  • C reactive protein

  • Cathelicidin

  • Lymphocyte to monocyte ratio

Drug/Treatment

  • Ergocalciferol

  • Kristalose Oral

  • cholecalciferol

Outcome

  • N/A

Study Design

  • randomized

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved